A detailed history of Bessemer Group Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 7,944 shares of MRNA stock, worth $522,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,944
Previous 7,258 9.45%
Holding current value
$522,318
Previous $774,000 21.83%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $69,430 - $114,294
686 Added 9.45%
7,944 $943,000
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $23,562 - $31,861
276 Added 3.95%
7,258 $774,000
Q4 2023

Feb 09, 2024

BUY
$69.51 - $104.43 $74,028 - $111,217
1,065 Added 18.0%
6,982 $694,000
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $535,364 - $703,065
-5,553 Reduced 48.41%
5,917 $611,000
Q2 2023

Aug 10, 2023

BUY
$118.5 - $160.53 $497,937 - $674,547
4,202 Added 57.82%
11,470 $1.39 Million
Q1 2023

May 10, 2023

SELL
$135.66 - $197.02 $43,818 - $63,637
-323 Reduced 4.26%
7,268 $1.12 Million
Q4 2022

Feb 13, 2023

BUY
$118.38 - $210.04 $143,239 - $254,148
1,210 Added 18.96%
7,591 $1.36 Million
Q3 2022

Nov 09, 2022

SELL
$118.07 - $194.18 $127,633 - $209,908
-1,081 Reduced 14.49%
6,381 $755,000
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $500,847 - $755,098
4,276 Added 134.21%
7,462 $1.07 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $117,860 - $219,066
932 Added 41.35%
3,186 $548,000
Q4 2021

Jan 27, 2022

SELL
$225.82 - $368.51 $21,904 - $35,745
-97 Reduced 4.13%
2,254 $573,000
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $499,496 - $1.09 Million
2,251 Added 2251.0%
2,351 $905,000
Q2 2021

Aug 06, 2021

BUY
$129.91 - $234.98 $12,991 - $23,498
100 New
100 $24,000
Q4 2020

Feb 09, 2021

SELL
$65.74 - $169.86 $3,944 - $10,191
-60 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$54.34 - $94.85 $19,562 - $34,146
-360 Reduced 85.71%
60 $4,000
Q2 2020

Aug 05, 2020

BUY
$29.67 - $80.0 $12,461 - $33,600
420 New
420 $27,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.